Tonghua Dongbao Pharmaceutical Co Ltd (600867) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million ≈ $9.22 Million USD) by net assets (CN¥7.14 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Tonghua Dongbao Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Tonghua Dongbao Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Elkem ASA
OL:ELK
0.023x
Hyosung Corp
KO:004800
0.117x
Payoneer Global Inc
NASDAQ:PAYO
0.079x
BaoJi Titanium Industry Co Ltd
SHG:600456
0.022x
Maxvision Technology Corp
SHE:002990
0.031x
GavYam Lands Corp Ltd
TA:GVYM
0.019x
Shenzhen Mason Technologies Co Ltd
SHE:002654
0.155x
Definium Therapeutics, Inc.
NASDAQ:DFTX
-0.126x

Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Tonghua Dongbao Pharmaceutical Co Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥7.11 Billion
≈ $1.04 Billion
CN¥689.23 Million
≈ $100.86 Million
0.097x +35.00%
2024-12-31 CN¥6.40 Billion
≈ $936.58 Million
CN¥459.74 Million
≈ $67.27 Million
0.072x -39.83%
2023-12-31 CN¥7.22 Billion
≈ $1.06 Billion
CN¥861.52 Million
≈ $126.07 Million
0.119x -9.40%
2022-12-31 CN¥6.55 Billion
≈ $958.41 Million
CN¥863.09 Million
≈ $126.30 Million
0.132x -27.75%
2021-12-31 CN¥6.22 Billion
≈ $910.21 Million
CN¥1.13 Billion
≈ $166.02 Million
0.182x -14.95%
2020-12-31 CN¥5.56 Billion
≈ $813.52 Million
CN¥1.19 Billion
≈ $174.47 Million
0.214x -6.77%
2019-12-31 CN¥5.01 Billion
≈ $732.95 Million
CN¥1.15 Billion
≈ $168.60 Million
0.230x +24.18%
2018-12-31 CN¥4.73 Billion
≈ $692.77 Million
CN¥876.94 Million
≈ $128.32 Million
0.185x -12.56%
2017-12-31 CN¥4.54 Billion
≈ $663.97 Million
CN¥961.19 Million
≈ $140.65 Million
0.212x +15.15%
2016-12-31 CN¥3.95 Billion
≈ $577.31 Million
CN¥725.76 Million
≈ $106.20 Million
0.184x +54.81%
2015-12-31 CN¥2.48 Billion
≈ $362.76 Million
CN¥294.58 Million
≈ $43.11 Million
0.119x +24.69%
2014-12-31 CN¥2.16 Billion
≈ $316.15 Million
CN¥205.89 Million
≈ $30.13 Million
0.095x -13.08%
2013-12-31 CN¥2.02 Billion
≈ $295.04 Million
CN¥221.06 Million
≈ $32.35 Million
0.110x +12.35%
2012-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥194.32 Million
≈ $28.44 Million
0.098x +468.21%
2011-12-31 CN¥2.08 Billion
≈ $304.07 Million
CN¥-55.07 Million
≈ $-8.06 Million
-0.027x -128.63%
2010-12-31 CN¥1.73 Billion
≈ $253.53 Million
CN¥160.40 Million
≈ $23.47 Million
0.093x -9.39%
2009-12-31 CN¥1.63 Billion
≈ $238.04 Million
CN¥166.20 Million
≈ $24.32 Million
0.102x +58.67%
2008-12-31 CN¥1.43 Billion
≈ $209.78 Million
CN¥92.31 Million
≈ $13.51 Million
0.064x -18.33%
2007-12-31 CN¥1.53 Billion
≈ $224.47 Million
CN¥120.94 Million
≈ $17.70 Million
0.079x -36.33%
2006-12-31 CN¥1.28 Billion
≈ $186.72 Million
CN¥158.00 Million
≈ $23.12 Million
0.124x +80.01%
2005-12-31 CN¥1.34 Billion
≈ $196.19 Million
CN¥92.23 Million
≈ $13.50 Million
0.069x +592.91%
2004-12-31 CN¥1.33 Billion
≈ $194.05 Million
CN¥13.17 Million
≈ $1.93 Million
0.010x -69.43%
2003-12-31 CN¥1.40 Billion
≈ $205.04 Million
CN¥45.51 Million
≈ $6.66 Million
0.032x +38.36%
2002-12-31 CN¥1.36 Billion
≈ $199.45 Million
CN¥31.99 Million
≈ $4.68 Million
0.023x -72.51%
2001-12-31 CN¥1.38 Billion
≈ $201.72 Million
CN¥117.73 Million
≈ $17.23 Million
0.085x +317.87%
2000-12-31 CN¥1.43 Billion
≈ $208.52 Million
CN¥29.12 Million
≈ $4.26 Million
0.020x +130.19%
1999-12-31 CN¥1.40 Billion
≈ $205.54 Million
CN¥-95.09 Million
≈ $-13.91 Million
-0.068x +71.02%
1998-12-31 CN¥928.90 Million
≈ $135.93 Million
CN¥-216.98 Million
≈ $-31.75 Million
-0.234x --

About Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.14 Billion
CN¥14.61 Billion CNY
Market Cap Rank
#6085 Global
#1271 in China
Share Price
CN¥7.46
Change (1 day)
+1.22%
52-Week Range
CN¥7.37 - CN¥10.49
All Time High
CN¥23.57
About

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more